Business Context and Reporting Period
Prestige Consumer Healthcare Inc. filed this Form 8-K on January 14, 2019. The filing reports preliminary unaudited revenue results for the third quarter ended December 31, 2018, and provides updated guidance for fiscal year 2019. The company also disclosed the commencement of investor presentations utilizing slides containing non-GAAP financial measures.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. It references a press release (Exhibit 99.1) and an investor presentation (Exhibit 99.2) containing these details, but the specific figures are not included in the body of this 8-K document.
Material Changes
The filing indicates the issuance of updated fiscal year 2019 guidance and preliminary third-quarter revenue results. No specific quantitative changes versus prior periods are detailed in the text of this report.
Guidance, Outlook, and Risks
- Guidance: The company issued updated fiscal year 2019 guidance on January 14, 2019.
- Non-GAAP Measures: The company utilizes non-GAAP financial measures in its investor presentations to provide additional context on operations and shareholder value. Reconciliations to GAAP measures are available in the referenced exhibits and prior earnings releases.
- Forward-Looking Statements: The company undertakes no obligation to update or revise the information contained in the investor presentation, though it may do so as management deems warranted.
- Liability Disclaimer: Information in Items 2.02 and 7.01 and the associated exhibits is not deemed "filed" under Section 18 of the Exchange Act unless specifically stated otherwise.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific preliminary Q3 2018 revenue figures.
- Review Exhibit 99.2 (Investor Presentation) for detailed fiscal year 2019 guidance and non-GAAP metrics.
- Verify the reconciliation of non-GAAP measures to GAAP net income and operating cash flow as referenced in the filing.
- Confirm the specific nature of the updated guidance compared to prior forecasts.